Home/Filings/4/0001072613-06-002595
4//SEC Filing

INTEGRATED PHARMACEUTICALS INC 4

Accession 0001072613-06-002595

CIK 0001265449operating

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 11:55 AM ET

Size

10.6 KB

Accession

0001072613-06-002595

Insider Transaction Report

Form 4
Period: 2006-12-19
Transactions
  • Purchase

    Common Stock

    2006-12-19$0.06/sh+250,000$15,000267,400 total
  • Purchase

    Common Stock Purchase Warrant

    2006-12-19+125,000125,000 total
    Exercise: $0.35From: 2006-12-19Exp: 2008-06-30Common Stock (125,000 underlying)
Holdings
  • Common Stock Purchase Warrant

    (indirect: See Footnote 1)
    Exercise: $2.50Common Stock (0 underlying)
    150,000
  • Common Stock Purchase Warrant

    Exercise: $1.00Common Stock (0 underlying)
    150,000
  • Common Stock

    (indirect: See Footnote 1)
    300,599
Footnotes (2)
  • [F1]Shares and warrants held indirectly are held in trust by Charles Schwab & Co., Inc. FBO IRAs in the name of the reporting person. Warrants held indirectly were exercisable immediately upon issuance in 2004, and are scheduled to expire on December 31, 2006.
  • [F2]The warrant held directly became exercisable with respect to 60,000 shares on July 1, 2004, 30,000 shares on July 1, 2005, and 30,000 shares on July 1, 2006. It becomes exercisable with respect to 30,000 additional shares on July 1, 2007. It is scheduled to expire on July 1, 2011.

Issuer

INTEGRATED PHARMACEUTICALS INC

CIK 0001265449

Entity typeoperating

Related Parties

1
  • filerCIK 0001265449

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 11:55 AM ET
Size
10.6 KB